Keiichi Moriya Yara Yukie Kikuti Joaquim Carreras Yusuke Kondo Sawako Shiraiwa Naoya Nakamura
10.3960/jslrt.19038
J Clin Exp Hematop
2020;60(1):11-16.
ebv-positive mucocutaneous ulcer epstein-barr virus other iatrogenic immunodeficiency-associated lymphoproliferative disorders diffuse large b-cell lymphoma methotrexate
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/32224560/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Composite Lymphoma / chemically induced Immunosuppressive Agents / adverse effects Lymphoma, Large B-Cell, Diffuse / chemically induced Methotrexate / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Composite Lymphoma / chemically induced Immunosuppressive Agents / adverse effects Lymphoma, Large B-Cell, Diffuse / chemically induced Methotrexate / adverse effects Case Reports Aged, 80 and over Composite Lymphoma / complications Composite Lymphoma / diagnosis Composite Lymphoma / drug therapy Cyclophosphamide / therapeutic use Doxorubicin / therapeutic use Epstein-Barr Virus Infections / complications Epstein-Barr Virus Infections / diagnosis Female Humans Lymphoma, Large B-Cell, Diffuse / complications Lymphoma, Large B-Cell, Diffuse / diagnosis Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoproliferative Disorders / chemically induced Lymphoproliferative Disorders / complications Lymphoproliferative Disorders / diagnosis Lymphoproliferative Disorders / drug therapy Pharynx / drug effects Pharynx / pathology Prednisone / therapeutic use Rituximab / therapeutic use Ulcer / chemically induced Ulcer / complications Ulcer / diagnosis Vincristine / therapeutic use Immunosuppressive Agents R-CHOP protocol Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone Methotrexate
PMC7187679
32224560
Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer
2020